Filing Details

Accession Number:
0001235802-19-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-11 16:35:36
Reporting Period:
2019-03-07
Accepted Time:
2019-03-11 16:35:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492658 Wright Medical Group N.v. WMGI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1244241 D David Stevens 1023 Cherry Road
Memphis TN 38117
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, Par Value Eur 0.03 Per Share Acquisiton 2019-03-07 10,309 $15.01 90,416 No 4 M Direct
Ordinary Shares, Par Value Eur 0.03 Per Share Disposition 2019-03-07 4,975 $31.46 85,441 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (right to buy) Disposition 2019-03-07 10,309 $0.00 10,309 $15.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-05-13 No 4 M Direct
Footnotes
  1. The reporting person exercised this option because the option was in the money and scheduled to expire on May 13, 2019.
  2. Total holdings were increased by one ordinary share due to a rounding error in the Form 4 report that was filed with the SEC on July 26, 2018.
  3. Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.45 to $31.48, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
  5. This option has fully vested.